Uromigos Live-Bladder Cancer
Tom moderates a live panel featuring Drs. Kala Sridhar, Shilpa Gupta, Andrea Apolo and Petros Grivas on emerging ADC data. Petros Grivas, MD, PhD, Director of UW Medicine's GU Cancers Program, talks about the efficacy of sacituzumab govitecan. Shilpa Gupta, MD discusses maintenance therapy for bladder cancer, including the current standard of care and ongoing trials. Thomas Powles, MBBS, MRCP, MD gives an overview of highlights from The Uromigos: Live & Unplugged bladder cancer session. Matthew Galsky, MD gives insight on adjuvant nivolumab trials, including use in unselected patients and overall survival. Kala Sridhar talks about bladder-sparing treatments for urothelial carcinoma and how patient populations are shifting. Jonathan Rosenberg, MD talks about the development of enfortumab vedotin, including monotherapy info and combination data. The bladder cancer buzzer round from The Uromigos: Live & Unplugged.